New drug M6229 put to the test in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested the safety of a new drug, M6229, in 15 healthy adults. Participants received the drug or a placebo as a continuous infusion over 5 days. The goal was to check for side effects and how the body processes the drug, not to treat any disease.
Phase: PHASE1 • Sponsor: Matisse Pharmaceuticals • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC